[The efficacy of sinuforte in the starting monotherapy of the patients presenting with acute rhinosinusitis].

The present randomized open study included 30 patients with acute suppurative rhinosinusitis. The efficacy of the treatment was estimated from the dynamics of the patients' subjective sensations and the objective assessment of clinical manifestations of the disease on days 1, 3, 5, and 7 after the onset of therapy. All the patients were prescribed treatment with sinuforte (one dose administered daily into each half of the nasal cavity at one and the same time). It was shown that monotherapy with sinuforte for the treatment of patients presenting with acute suppurative rhinosinusitis of moderate severity ensured the recovery in 73% of the cases.